Urgent reversal of warfarin with prothrombin complex concentrate

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 5, 2006, Pages 967-970

  Lankiewicz, Michael W ^a   Hays, J ^b   Friedman, K D ^a   Tinkoff, G ^b   Blatt, P M ^b  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b CHRISTIANA CARE HEALTH SYSTEM   (United States)

Author keywords

Anticoagulation reversal; Bleeding; Prothrombin complex concentrate; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 9 CONCENTRATE; CLOPIDOGREL; FRESH FROZEN PLASMA; PROPLEX T; PROTHROMBIN COMPLEX; VITAMIN K GROUP; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTERIOVENOUS FISTULA; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CARDIOMYOPATHY; CLINICAL FEATURE; CLINICAL PROTOCOL; CRANIOTOMY; DEEP VEIN THROMBOSIS; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG INDICATION; EMERGENCY CARE; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART VALVE PROSTHESIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; PACEMAKER; PLASMA TRANSFUSION; PRIORITY JOURNAL; PROTHROMBIN TIME; RISK ASSESSMENT; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; SURGICAL DRAINAGE; THORACOTOMY; THROMBOSIS; VEIN THROMBOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; FEASIBILITY STUDIES; HEMORRHAGE; HUMANS; MIDDLE AGED; PROTHROMBIN; WARFARIN;

EID: 33645637952     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01815.x     Document Type: Article

References (14)

1. Fihn SD, Callahan CM, Martin DC, McDonell MB, Henikoff JG, White RH. The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics. Ann Intern Med 1996; 124: 970-9.
2. Parletti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, Pengo V, Erba N, Moia M, Ciavarella N, Devoto G, Berrettini M, Musolesi S. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996; 348: 423-428.
3. Byeth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998; 105: 91-9.
4. Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR, Preston FE. Emergency oral anticoagulation reversal. The relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 1997; 77: 477-80.
5. Boulis NM, Bobek MP, Schmaier A, Hoff JT. Use of Factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery 1999; 45: 1118-9.
6. Roberts HR, Eberst ME. Current management of hemophilia B. Hematol Oncol Clin North Am 1993; 7: 1269-1280.
7. Fredricksson K, Norrving B, Stromblad LG. Emergency reversal of anticoagulation after intracranial hemorrhage. Stroke 1992; 23: 972-7.
8. Nitu IC, Perry DJ, Lee CA. Clinical experience with the use of clotting factor concentrates in oral anticoagulation reversal. Clin Lab Haematol 1998; 20: 363-367.
9. Pengo V, Legnani C, Noventa F, Parletti G. Oral anticoagulation therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. Thromb Haemost 2001; 85: 418-22.
10. Lusher JM, Thrombogenicity associated with factor IX complex concentrates. Semin Hematol 1991; 28: 3-5.
11. Deveras RE, Kessler CM. Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med 2002; 137; 884-888.
12. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005; 352: 777-85.
13. Duguid J, O'Shaughnessy DF. Atterbury C, Bolton Maggs P, Murphy M, Thomas D, Yates S, Williamson LM. Guidelines for the use of fresh frozen plasma, cryoprecipitate and cryosupernatant. British Committee for Standards in Haematology Blood Transfusion task force. Br J Haematol 2004; 126: 11-28.
14. Ansel J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The Pharmacology and management of vitamin K antagonists. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126: 204S-33S.